KRT7 siRNA (Rat)
SiRNA to inhibit KRT7 expression using RNA interference
Product Specifications
Product Name Alternative
KB7; KRT2-7; Keratin type II cytoskeletal 7; Cytokeratin-7; CK-7; Keratin-7; K7; Type-II keratin Kb7
Reactivity
Rat
Source
Synthetic
Purity
> 97%
Form
Liquid
Storage Conditions
Shipped at 4 °C. Store at -20 °C for one year.
Notes
For research use only.
Applications Notes
Components: We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of rat KRT7 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Directions for Use: We recommends transfection with 10 nM - 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For example, resuspend one tube of 5 nmol siRNA oligo in 250 μl of DEPC water to get a final concentration of 20 μM
Tested Applications
RNA-I
Entrez
300242, 0
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
254136 2 mL
Lamin A/C (70kD Lamin, Cardiomyopathy Dilated 1A (Autosomal Dominant), CDCD1, CDDC, Charcot Marie Tooth Disease Axonal Type 2B1, CMD1A, CMT2B1, EMD2, FPL, FPLD, HGPS, IDC, Lamin A/C, Lamin A/C Isoform 1Precursor, Lamin A/C Isoform 2, Lamin A/C Isoform 3, LDP1, LFP, LGMD1B, Limb girdle muscular dystrophy 1B (Autosomal Dominant), LMN 1, LMN A, LMN C, LMN1, LMNA, LMNC, NY REN 32 antigen, PRO1, Progeria 1 (Hutchinson Gilford Type), Renal carcinoma antigen NY REN 32, Renalcarcinoma antigen NYREN32)
Sign In for Pricing
View Details